$LFCR
LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr

$lfcr Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000100528622000062 Filed on October 07, 2022

Income Statement

Concept	2022 Q4	2022 Q3
Revenue	$38.80M	$43.36M
YoY Change	-70.04%	-66.34%
Cost Of Revenue	$31.69M	$37.53M
YoY Change	-72.79%	-66.27%
Gross Profit	$7.108M	$5.821M
YoY Change	-45.29%	-66.77%
Gross Profit Margin	18.32%	13.43%
Selling, General & Admin	$10.77M	$10.88M
YoY Change	-22.13%	-31.72%
% of Gross Profit	151.56%	186.96%
Research & Development	$2.118M	$2.048M
YoY Change	-22.08%	-27.53%
% of Gross Profit	29.8%	35.18%
Depreciation & Amortization	$2.880M	$5.009M
YoY Change	-51.23%	-0.89%
% of Gross Profit	40.52%	86.05%
Operating Expenses	$15.01M	$13.98M
YoY Change	-69.99%	-34.46%
Operating Profit	-$7.906M	-$8.157M
YoY Change	-78.65%	114.21%
Interest Expense	$4.219M	$3.678M
YoY Change	-2.63%	-53.54%
% of Operating Profit
Other Income/Expense, Net	-$336.0K	-$180.0K
YoY Change	-525.32%	-265.14%
Pretax Income	-$12.45M	-$12.00M
YoY Change	-69.84%	3.55%
Income Tax	$4.000K	$64.00K
% Of Pretax Income
Net Earnings	-$12.45M	-$12.06M
YoY Change	-67.62%	27.3%
Net Earnings / Revenue	-32.08%	-27.83%
Basic Earnings Per Share	-$0.42	-$0.41
Diluted Earnings Per Share	-$0.42	-$0.41
COMMON SHARES
Basic Shares Outstanding	29.60M shares	29.60M shares
Diluted Shares Outstanding	29.63M shares	29.58M shares

Balance Sheet

Concept	2022 Q4	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.800M	$4.222M
YoY Change	523.28%	191.78%
Cash & Equivalents	$6.830M	$4.222M
Short-Term Investments
Other Short-Term Assets	$7.000M	$7.157M
YoY Change	-19.73%	-25.38%
Inventory	$77.52M	$64.29M
Prepaid Expenses
Receivables	$35.69M	$40.93M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$127.1M	$116.6M
YoY Change	-17.75%	-18.12%
LONG-TERM ASSETS
Property, Plant & Equipment	$118.9M	$129.0M
YoY Change	-33.95%	-28.5%
Goodwill	$13.88M	$13.88M
YoY Change	-62.81%	-79.99%
Intangibles	$7.400M	$8.400M
YoY Change	-70.78%	-66.84%
Long-Term Investments
YoY Change
Other Assets	$2.605M	$2.793M
YoY Change	-19.57%	-18.86%
Total Long-Term Assets	$152.0M	$169.2M
YoY Change	-43.21%	-44.2%
TOTAL ASSETS
Total Short-Term Assets	$127.1M	$116.6M
Total Long-Term Assets	$152.0M	$169.2M
Total Assets	$279.1M	$285.8M
YoY Change	-33.89%	-35.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$27.97M	$16.37M
YoY Change	-52.67%	-64.69%
Accrued Expenses	$20.00M	$19.23M
YoY Change	-0.03%	-20.16%
Deferred Revenue	$731.0K	$803.0K
YoY Change	-36.98%	-33.96%
Short-Term Debt	$48.00M	$44.00M
YoY Change	14.29%	37.5%
Long-Term Debt Due	$98.95M	$2.704M
YoY Change
Total Short-Term Liabilities	$195.7M	$83.10M
YoY Change	60.06%	-19.83%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$95.87M
YoY Change	-100.0%	-22.59%
Other Long-Term Liabilities	$201.0K	$199.0K
YoY Change	-94.84%	-93.59%
Total Long-Term Liabilities	$201.0K	$96.06M
YoY Change	-99.84%	-24.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$195.7M	$83.10M
Total Long-Term Liabilities	$201.0K	$96.06M
Total Liabilities	$204.9M	$188.9M
YoY Change	-22.95%	-24.97%
SHAREHOLDERS EQUITY
Retained Earnings	-$99.90M	-$70.92M
YoY Change	969.81%	-343.67%
Common Stock	$30.00K	$30.00K
YoY Change	3.45%	3.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$74.17M	$96.90M
YoY Change
Total Liabilities & Shareholders Equity	$279.1M	$285.8M
YoY Change	-33.89%	-35.86%

Cashflow Statement

Concept	2022 Q4	2022 Q3
OPERATING ACTIVITIES
Net Income	-$12.45M	-$12.06M
YoY Change	-67.62%	27.3%
Depreciation, Depletion And Amortization	$2.880M	$5.009M
YoY Change	-51.23%	-0.89%
Cash From Operating Activities	-$2.950M	-$1.533M
YoY Change	-42.57%	-284.48%
INVESTING ACTIVITIES
Capital Expenditures	$3.250M	$2.929M
YoY Change	-163.76%	-62.98%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$3.135M
YoY Change		-93.21%
Cash From Investing Activities	-$3.260M	$206.0K
YoY Change	-36.04%	-99.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$27.00K
YoY Change		-99.93%
Cash From Financing Activities	8.810M	$3.906M
YoY Change	-10.81%	-110.03%
NET CHANGE
Cash From Operating Activities	-2.950M	-$1.533M
Cash From Investing Activities	-3.260M	$206.0K
Cash From Financing Activities	8.810M	$3.906M
Net Change In Cash	2.600M	$2.579M
YoY Change	-830.34%	1596.71%
FREE CASH FLOW
Cash From Operating Activities	-$2.950M	-$1.533M
Capital Expenditures	$3.250M	$2.929M
Free Cash Flow	-$6.200M	-$4.462M
YoY Change	15400.0%	-37.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001005286
CY2022Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--05-29
CY2022Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2022Q3	dei	Amendment Flag AmendmentFlag	false
CY2022Q3	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2022#ProductMember
CY2021Q3	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2022#ProductMember
CY2021Q3	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2022#ProductMember
CY2022Q3	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2022#ProductMember
CY2022Q3	dei	Document Type DocumentType	10-Q
CY2022Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q3	dei	Document Period End Date DocumentPeriodEndDate	2022-08-28
CY2022Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q3	dei	Entity File Number EntityFileNumber	000-27446
CY2022Q3	dei	Entity Registrant Name EntityRegistrantName	LANDEC CORPORATION
CY2022Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-3025618
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	6900000	usd
CY2022Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	2811 Airpark Drive
CY2022Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Santa Maria,
CY2022Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	93455
CY2022Q3	dei	City Area Code CityAreaCode	650
CY2022Q3	dei	Local Phone Number LocalPhoneNumber	306-1650
CY2022Q3	dei	Security12b Title Security12bTitle	Common stock, par value $0.001 per share
CY2022Q3	dei	Trading Symbol TradingSymbol	LNDC
CY2022Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q3	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2022Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q3	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q3	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	29595554	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4222000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1643000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40934000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	48172000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	64285000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	66845000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7157000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7052000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	116598000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	123712000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	129024000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	130435000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8229000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8580000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	13881000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	13881000	usd
CY2022Q3	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	8400000	usd
CY2022Q2	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	8400000	usd
CY2022Q3	lndc	Finite Lived Customer Lists Net FiniteLivedCustomerListsNet	6875000	usd
CY2022Q2	lndc	Finite Lived Customer Lists Net FiniteLivedCustomerListsNet	7150000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2793000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3002000	usd
CY2022Q3	us-gaap	Assets Assets	285800000	usd
CY2022Q2	us-gaap	Assets Assets	295160000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	16366000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	15802000	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6373000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9238000	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7832000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7647000	usd
CY2022Q3	lndc	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	5021000	usd
CY2022Q2	lndc	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	5026000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	803000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	919000	usd
CY2022Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	44000000	usd
CY2022Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	40000000	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	2704000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	599000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	83099000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	79231000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	95865000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	97579000	usd
CY2022Q3	lndc	Operating And Finance Lease Liability Noncurrent OperatingAndFinanceLeaseLiabilityNoncurrent	9447000	usd
CY2022Q2	lndc	Operating And Finance Lease Liability Noncurrent OperatingAndFinanceLeaseLiabilityNoncurrent	9983000	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	291000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	232000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	199000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	190000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	188901000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	187215000	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29593000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29593000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29513000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29513000	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	30000	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	30000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	168070000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	167352000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-70915000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-58851000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-286000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-586000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	96899000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	107945000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	285800000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	295160000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	43355000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	41632000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	37534000	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	31197000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	5821000	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	10435000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2048000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1873000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10883000	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9470000	usd
CY2022Q3	us-gaap	Restructuring Charges RestructuringCharges	1047000	usd
CY2021Q3	us-gaap	Restructuring Charges RestructuringCharges	1834000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	13978000	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	13177000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8157000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2742000	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	15000	usd
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	27000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	3678000	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	6678000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-180000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	109000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12000000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9284000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	64000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1651000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-12064000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-7633000	usd
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	usd
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1844000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-12064000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-9477000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.41
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.26
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.06
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.41
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.26
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.06
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29577000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29424000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29577000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29424000	shares
CY2022Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-16000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-90000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	300000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	366000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	300000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	366000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11764000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9111000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	107945000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2022Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	67000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	785000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-12064000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	300000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	96899000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	202784000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2021Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	428000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	620000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-9477000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	366000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	193865000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-12064000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-9477000	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5009000	usd
CY2021Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5054000	usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	2108000	usd
CY2021Q3	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	785000	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	620000	usd
CY2022Q3	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	43000	usd
CY2021Q3	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-2138000	usd
CY2022Q3	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	0	usd
CY2021Q3	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	-92000	usd
CY2022Q3	lndc	Discontinued Operations Credit Loss Expense Reversal DiscontinuedOperationsCreditLossExpenseReversal	0	usd
CY2021Q3	lndc	Discontinued Operations Credit Loss Expense Reversal DiscontinuedOperationsCreditLossExpenseReversal	60000	usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2021Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-16000	usd
CY2022Q3	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	18000	usd
CY2021Q3	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	70000	usd
CY2022Q3	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-7238000	usd
CY2021Q3	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-7997000	usd
CY2022Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2560000	usd
CY2021Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-248000	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	761000	usd
CY2021Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2697000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	581000	usd
CY2021Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1517000	usd
CY2022Q3	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2865000	usd
CY2021Q3	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-3131000	usd
CY2022Q3	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	183000	usd
CY2021Q3	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	2838000	usd
CY2022Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-116000	usd
CY2021Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	86000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1533000	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	831000	usd
CY2022Q3	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	3135000	usd
CY2021Q3	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2929000	usd
CY2021Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7913000	usd
CY2022Q3	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	usd
CY2021Q3	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	45100000	usd
CY2022Q3	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2021Q3	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1082000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	206000	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	38269000	usd
CY2022Q3	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	27000	usd
CY2021Q3	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	41388000	usd
CY2022Q3	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	4000000	usd
CY2021Q3	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	8000000	usd
CY2022Q3	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2021Q3	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	5000000	usd
CY2022Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	67000	usd
CY2021Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	428000	usd
CY2022Q3	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2021Q3	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	132000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3906000	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-38948000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2579000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	152000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1643000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1295000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4222000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1447000	usd
CY2022Q3	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2243000	usd
CY2021Q3	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1994000	usd
CY2022Q3	lndc	Number Of Product Category NumberOfProductCategory	2	product
CY2022Q3	lndc	Number Of Revenue Category NumberOfRevenueCategory	3	revenue
CY2022Q3	us-gaap	Fiscal Period FiscalPeriod	The Company’s fiscal year is the 52- or 53-week period that ends on the last Sunday of May with quarters within each year ending on the last Sunday of August, November, and February; however, in instances where the last Sunday would result in a quarter being 12-weeks in length, the Company’s policy is to extend that quarter to the following Sunday. A 14th week is included in the fiscal year every five or six years to realign the Company’s fiscal quarters with calendar quarters.The results of operations for the three months ended August 28, 2022 are not necessarily indicative of the results that may be expected for an entire fiscal year because there is some seasonality in Curation Foods’ business and the order patterns of Lifecore’s customers which may lead to significant fluctuations in Landec’s quarterly results of operations.
CY2022Q3	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make certain estimates and judgments that affect the amounts reported in the financial statements and accompanying notes. The accounting estimates that require management’s most significant and subjective judgments include revenue recognition; loss contingencies; sales returns and credit losses; recognition and measurement of current and deferred income tax assets and liabilities; the assessment of recoverability of long-lived and indefinite lived assets (including intangible assets and goodwill), and inventory; and the valuation and recognition of stock-based compensation.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates involve the consideration of complex factors and require management to make judgments. The analysis of historical and future trends can require extended periods of time to resolve and are subject to change from period to period. The actual results may differ from management’s estimates.</span></div>
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4222000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1643000	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1406000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1159000	usd
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	0	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	0	usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	41000	usd
CY2021Q2	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	136000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4222000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1643000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1447000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1295000	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	25266000	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	33029000	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	27402000	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	24221000	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	11617000	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	9595000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	64285000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	66845000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	300000	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	620000	usd
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	85000	usd
CY2021Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	85000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	65000	usd
CY2022Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	65000	usd
CY2022Q3	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	1500000	usd
CY2022Q3	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	3600000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	1500000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	4000000.0	usd
CY2022Q3	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	-300000	usd
CY2021Q1	us-gaap	Insurance Recoveries InsuranceRecoveries	1600000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	725000	shares
CY2022Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3600000	shares
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	785000	usd
CY2010Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	10000000	usd
CY2022Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	3800000	usd
CY2022Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2021Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-12064000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-9477000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	29577000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	29424000	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29577000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29424000	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1700000	usd
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.01
CY2021Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.18
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1100000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1000000	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1000000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	900000	usd
CY2022Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	103712000	usd
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	103712000	usd
CY2022Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	103712000	usd
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	103712000	usd
CY2022Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5143000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5534000	usd
CY2022Q3	us-gaap	Long Term Debt LongTermDebt	98569000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	98178000	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	2704000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	599000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	95865000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	97579000	usd
CY2020Q4	lndc	Number Of Credit Agreements NumberOfCreditAgreements	2	creditagreement
CY2022Q3	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2022Q3	lndc	Number Of Natural Food Brands NumberOfNaturalFoodBrands	3	brand
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	43355000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	5821000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-12064000	usd
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	4602000	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	15000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	3678000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	64000	usd
CY2022Q3	lndc	Corporate Overhead Expense Benefit CorporateOverheadExpenseBenefit	0	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	41632000	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	10435000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-7633000	usd
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1844000	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	2454000	usd
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	27000	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	6678000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1651000	usd
CY2021Q3	lndc	Corporate Overhead Expense Benefit CorporateOverheadExpenseBenefit	0	usd
CY2022Q3	us-gaap	Restructuring Costs RestructuringCosts	1047000	usd
	us-gaap	Restructuring Costs RestructuringCosts	17825000	usd
CY2022Q3	us-gaap	Restructuring And Related Cost Expected Cost1 RestructuringAndRelatedCostExpectedCost1	23000000	usd

Files In Submission

Name	View Source	Status
0001005286-22-000062-index-headers.html	Edgar Link	pending
0001005286-22-000062-index.html	Edgar Link	pending
0001005286-22-000062.txt	Edgar Link	pending
0001005286-22-000062-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lndc-20220828.htm	Edgar Link	pending
lndc-20220828.xsd	Edgar Link	pending
lndc-20220828xexx311.htm	Edgar Link	pending
lndc-20220828xexx312.htm	Edgar Link	pending
lndc-20220828xexx321.htm	Edgar Link	pending
lndc-20220828xexx322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
lndc-20220828_cal.xml	Edgar Link	unprocessable
lndc-20220828_def.xml	Edgar Link	unprocessable
lndc-20220828_lab.xml	Edgar Link	unprocessable
lndc-20220828_pre.xml	Edgar Link	unprocessable
lndc-20220828_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LFCR
LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr

2022 Q4 Form 10-Q Financial Statement

#000100528622000062 Filed on October 07, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFCR LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr

2022 Q4 Form 10-Q Financial Statement

#000100528622000062 Filed on October 07, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFCR
LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr